THERAPEUTIC AREA
savePain
Acute and chronic pain management.
also known as: analgesia, chronic pain, pain management
🐶 often sniffed alongside
top 8- tagRecall49 co-mentions · 43 sources
- tagOrthopedics47 co-mentions · 13 sources
- tagOncology16 co-mentions · 7 sources
- tagWomen's Health15 co-mentions · 4 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN15 co-mentions · 7 sources
- drugbupivacaine14 co-mentions · 14 sources
- drugImmunology14 co-mentions · 3 sources
- tagImmunology14 co-mentions · 3 sources
drugs
89
catalysts
15
news
793
companies
78
Top drugs
view all →Marketed
acetaminophen ER
Dysmenorrhea
1021 catalysts
MarketedMETHADONE HYDROCHLORIDE
Pain
343 catalysts
MarketedBUPRENORPHINE HYDROCHLORIDE
Pain
270 catalysts
Marketedcarbamazepine ER
Complex Partial Seizure
222 catalysts
MarketedMEPERIDINE HYDROCHLORIDE
Pain
165 catalysts
MarketedKapanol
Pain
148 catalysts
Marketedtramadol hydrochloride ER
Pain
146 catalysts
MarketedOXYCODONE HYDROCHLORIDE
$AVTR · 133 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Police General Hospital — acetaminophen (Phase II Trial Completion)
acetaminophen ER
→
Apr 30, 2026
phase 2 completion
Beijing Jishuitan Hospital — undisclosed anesthetic drug (Phase II Trial Completion)
undisclosed anesthetic drug
→
Apr 30, 2026
phase 2 completion
Assaf Harofeh Medical Center — acetaminophen (Phase II Trial Completion)
acetaminophen ER
→
Apr 30, 2026
phase 1 completion
$ECL297.32-1.12%
Ecolab Inc — (acetaminophen + ibuprofen) (Phase I Trial Completion)
(acetaminophen + ibuprofen)
→
Apr 30, 2026
phase 0 trial completion
Ruijin Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Kunming Yan'an Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 29, 2026
phase iii iv trial initiation
Chettinad Hospital and Research Institute — undisclosed local anesthesia (Phase III/IV Trial Initiation)
undisclosed local anesthesia
→
Apr 28, 2026
phase iv trial initiation
Rajendra Institute of Medical Sciences — levobupivacaine (Phase IV Trial Initiation)
levobupivacaine
→
Apr 27, 2026
phase 2 initiation
Central South University Xiangya Hospital 3 — HRS-2129 (Phase II Trial Initiation)
HRS-2129
→
Apr 27, 2026
phase 2 initiation
Yichun Maternal and Child health Care Hospital — sufentanil (Phase II Trial Initiation)
sufentanil
→
Recent news
view all →- nChroma halves workforce, BioXcel lets execs gobiospace · 9h ago
- Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic diseasebiospace · 10h ago
- Grand Strand Sandwich Company Recalls Lunch Box Bacon Egg and Cheese Biscuit, Lunch Box Jumbo Sausage Biscuit, Lunch Box Sausage Egg and Cheese Biscuit, Lunch Box Chicken Sausage Biscuit Due to Listeria Monocytogenes Contaminationfda recalls · 19h ago
- GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buybiospace · 1d ago
- Larbi Inc. Recalls Yellow Dock Root Because of Possible Health Riskfda recalls · 2d ago
- FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longerfda press · 2d ago
- Fresh & Ready Foods LLC Expands Recall to Include Fresh to You Brand Sausage, Egg & Cheese Biscuit Sandwich and Meals Made in Minutes Brand Biscuit & Sausage Gravy Due to Possible Health Riskfda recalls · 2d ago
- Vertex on the verge of ‘iconic’ evolution as key kidney disease verdict loomsbiospace · 2d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that